Target intelligence / Profile preview

Regulatory T cell-derived exosome

Molecular classification
Other (Extracellular vesicle, Exosome)
01

Overview

Regulatory T cell-derived exosomes are a type of extracellular vesicle, specifically exosomes (50–100 nm), secreted by regulatory T cells (Tregs) during immune responses[2]. These vesicles carry bioactive cargos such as proteins (e.g., CD73, CTLA-4), lipids, mRNAs, and microRNAs, enabling them to modulate the function of recipient immune cells. They can suppress effector T cell proliferation and cytokine production, contribute to immune tolerance (e.g., in transplantation), and may be involved in maintaining immune homeostasis or mediating immunosuppression in pathological conditions such as cancer and chronic inflammation[2][3]. The suppressive function of these exosomes involves surface enzymes like CD73 and the transfer of specific microRNAs, which downregulate immune activation in target cells. Regulatory T cell-derived exosomes are being investigated as possible therapeutic and diagnostic tools, but they are not a classical "drug target" such as a receptor, enzyme, or transporter—they are cell-derived products that exert multi-factorial regulatory effects[2][3][1].

Other names
Regulatory T cell exosomeTreg-derived exosomeTreg exosome
02

Biological functions

Immune response modulationSuppression of effector T cell functionIntercellular communicationTransfer of microRNAs, proteins, and cytokines
03

Disease associations

InflammationAutoimmunityTransplant rejection (allograft tolerance)Cancer (immunosuppression in tumor microenvironment)
04

Safety considerations

Potential for excessive immunosuppression if used therapeutically[2]Possible off-target effects due to transfer of microRNA and proteinsUnpredictable biodistribution and bioactivity
05

Biomarkers

CD73 (ectoenzyme mediating suppression)CD39CTLA-4 (present on exosome surface, not always functionally relevant)Specific microRNAs (e.g., Let-7d, miR-155, Let-7b, miR-150)

Beyond the preview

Go deeper on Regulatory T cell-derived exosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulatory T cell-derived exosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call